145 related articles for article (PubMed ID: 20721534)
1. Neutrophil gelatinase-associated lipocalin clearance during veno-venous continuous renal replacement therapy in critically ill patients.
de Geus HR; Betjes MG; Bakker J
Intensive Care Med; 2010 Dec; 36(12):2156-7. PubMed ID: 20721534
[No Abstract] [Full Text] [Related]
2. Neutrophil gelatinase-associated lipocalin levels during extracorporeal membrane oxygenation in critically ill children with congenital heart disease: preliminary experience.
Ricci Z; Morelli S; Favia I; Garisto C; Brancaccio G; Picardo S
Pediatr Crit Care Med; 2012 Jan; 13(1):e51-4. PubMed ID: 21057360
[TBL] [Abstract][Full Text] [Related]
3. Biomarkers for acute kidney injury: is the serum creatinine worthless?
Bunchman TE
Pediatr Crit Care Med; 2012 Jan; 13(1):119-20. PubMed ID: 22222659
[No Abstract] [Full Text] [Related]
4. The plasma level and biomarker value of neutrophil gelatinase-associated lipocalin in critically ill patients with acute kidney injury are not affected by continuous venovenous hemofiltration and anticoagulation applied.
Schilder L; Nurmohamed SA; ter Wee PM; Paauw NJ; Girbes AR; Beishuizen A; Beelen RH; Groeneveld AB
Crit Care; 2014 Apr; 18(2):R78. PubMed ID: 24755339
[TBL] [Abstract][Full Text] [Related]
5. Is neutrophil gelatinase-associated lipocalin unaffected by convective continuous renal replacement therapy? Definitely … maybe.
Honore PM; Jacobs R; Hendrickx I; De Waele E; Van Gorp V; Spapen HD
Crit Care; 2015 Nov; 19():392. PubMed ID: 26573621
[No Abstract] [Full Text] [Related]
6. Potential role of neutrophil gelatinase-associated lipocalin in identifying critically ill patients with acute kidney injury stage 2-3 who subsequently require renal replacement therapy.
Tiranathanagul K; Amornsuntorn S; Avihingsanon Y; Srisawat N; Susantitaphong P; Praditpornsilpa K; Tungsanga K; Eiam-Ong S
Ther Apher Dial; 2013 Jun; 17(3):332-8. PubMed ID: 23735150
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil gelatinase-associated lipocalin as a biomarker of acute kidney injury--where do we stand today?
Schmidt-Ott KM
Nephrol Dial Transplant; 2011 Mar; 26(3):762-4. PubMed ID: 21310736
[No Abstract] [Full Text] [Related]
8. [The effect of continuous veno venous hemofiltration on neutrophil gelatinase-associated lipocalin plasma levels in critically ill patients with acute kidney injury].
Wang H; Cui N; Zhou YK; Cheng W; Li L; Long Y; Liu DW
Zhonghua Nei Ke Za Zhi; 2018 Apr; 57(4):285-289. PubMed ID: 29614588
[No Abstract] [Full Text] [Related]
9. Intensive care.
Ricci Z; Cruz DN; Ronco C
Nephrol Dial Transplant; 2010 Mar; 25(3):678-83. PubMed ID: 20185413
[No Abstract] [Full Text] [Related]
10. The rise and fall of NGAL in acute kidney injury.
Mårtensson J; Bellomo R
Blood Purif; 2014; 37(4):304-10. PubMed ID: 25170751
[TBL] [Abstract][Full Text] [Related]
11. Neutrophil gelatinase-associated lipocalin elimination by renal replacement therapy: minding the membrane!
Honore PM; Spapen HD
Crit Care; 2016 Apr; 20():87. PubMed ID: 27044560
[No Abstract] [Full Text] [Related]
12. Urinary Neutrophil Gelatinase-Associated Lipocalin Predicts Renal Injury Following Extracorporeal Membrane Oxygenation.
Zwiers AJ; Cransberg K; de Rijke YB; van Rosmalen J; Tibboel D; de Wildt SN
Pediatr Crit Care Med; 2015 Sep; 16(7):663-70. PubMed ID: 26121099
[TBL] [Abstract][Full Text] [Related]
13. Neutrophil gelatinase-associated lipocalin.
Haase M; Bellomo R; Haase-Fielitz A
Curr Opin Crit Care; 2010 Dec; 16(6):526-32. PubMed ID: 20871395
[TBL] [Abstract][Full Text] [Related]
14. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis.
Haase M; Bellomo R; Devarajan P; Schlattmann P; Haase-Fielitz A;
Am J Kidney Dis; 2009 Dec; 54(6):1012-24. PubMed ID: 19850388
[TBL] [Abstract][Full Text] [Related]
15. Testing new biomarkers for acute kidney injury: association, prediction, and intervention.
Parikh CR; Garg AX
Am J Kidney Dis; 2009 Dec; 54(6):987-9. PubMed ID: 19932874
[No Abstract] [Full Text] [Related]
16. [Neutrophil gelatinase-associated lipocalin as a new diagnostic tool for acute kidney injury].
El Housseini Y; Schmidtko J; Meier P
Rev Med Suisse; 2013 Nov; 9(406):2101-6. PubMed ID: 24383284
[TBL] [Abstract][Full Text] [Related]
17. Neutrophil gelatinase-associated lipocalin--an emerging troponin for kidney injury.
Devarajan P
Nephrol Dial Transplant; 2008 Dec; 23(12):3737-43. PubMed ID: 18809975
[No Abstract] [Full Text] [Related]
18. Serum neutrophil gelatinase-associated lipocalin at inception of renal replacement therapy predicts survival in critically ill patients with acute kidney injury.
Kümpers P; Hafer C; Lukasz A; Lichtinghagen R; Brand K; Fliser D; Faulhaber-Walter R; Kielstein JT
Crit Care; 2010; 14(1):R9. PubMed ID: 20122150
[TBL] [Abstract][Full Text] [Related]
19. Whole blood assessment of neutrophil gelatinase-associated lipocalin versus pediatricRIFLE for acute kidney injury diagnosis and prognosis after pediatric cardiac surgery: cross-sectional study*.
Ricci Z; Netto R; Garisto C; Iacoella C; Favia I; Cogo P
Pediatr Crit Care Med; 2012 Nov; 13(6):667-70. PubMed ID: 22895007
[TBL] [Abstract][Full Text] [Related]
20. Continuous renal replacement therapy in critically ill patients does not affect urinary neutrophil gelatinase-associated lipocalin levels.
Vasileiadis I; Pipili C; Nanas S
Crit Care; 2015 Mar; 19(1):140. PubMed ID: 25887059
[No Abstract] [Full Text] [Related]
[Next] [New Search]
